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BACKGROUND: Vascular endothelial growth factor (VEGF) and brain-derived neurotrophic factor (BDNF) present during early neuronal 
development and play important roles in the process of 
neurorepairing includes angiogenesis, neurogenesis and 
neuronal plasticity after ischemic stroke. In this study, we 
observed VEGF and BDNF levels of subjects with ischemic 
stroke in different onset time.
METHODS: A cross sectional study was designed. Study 
subjects were 51 ischemic stroke subjects, aged 30-80 years 
old, recruited from Gatot Subroto Army Central Hospital, 
Jakarta, Indonesia. Ischemic stroke was diagnosed by 
neurologist, based on clinical examination and magnetic 
resonance imaging (MRI) result. Subjects were divided into 
3 groups based on onset time of stroke: <7 days (group A), 
7-30 days (group B) and >30 days (Group C). VEGF and 
BDNF levels from serum were measured using luminex 
Magpix. The data was analyzed for comparison and 
correlation.  
RESULTS: VEGF and BDNF levels of group B and C 
were significantly different with p=0.034 and p=0.007, 
respectively. Group B had the highest VEGF levels, whereas 
Group C had the highest BDNF level. VEGF and BDNF 
levels in each group were not significantly correlated. 
CONCLUSION: Each stage of time after ischemic stroke has 
different recovery activities like angiogenesis, neurogenesis 
and plasticity. Angiogenesis process was optimum in 7-30 
days after onset. In more than 30 days onset, Low VEGF 
with high BDNF have important role in a long period of 
time after the onset of stroke in the regeneration and repair, 
such as maintaining neuronal survival and plasticity. 
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Abstract
Introduction
Some growth factors are increased after ischemic 
stroke, include basic fibroblast growth factor (bFGF), 
vascular endothelial growth factor (VEGF), brain-
derived neurotrophic factor (BDNF) and others.(1-3) 
All neurotrophins can enhance recovery of ischemic 
stroke patients through the process of angiogenesis, 
neurogenesis and plasticity of neurons.(1) Angiogenic 
genes are upregulated within minutes upon the onset of 
cerebral ischemia and angiogenic proteins remain increased 
in the ischemic area for days to weeks.(1) The primary 
neurovascular responses during stroke recovery are thought 
to involve angiogenesis and neurogenesis.(4,5)
 VEGF is a hypoxia-inducible protein that promotes 
angiogenesis through receptor tyrosine kinases on endothelial 
cells.(6) In patients with ischemic stroke, VEGF increases 
process and stimulates angiogenesis in penumbra.(7) The 
number of new blood vessel in penumbra is correlated with 
survival period.(8) VEGF also acts as an angiogenic protein 
with neurotrophic and neuroprotective effects (9), including 
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increase neurogenesis (6) and can stimulates axon growth 
from dorsal root ganglia (DRG), superior cervical ganglion 
(SCG) and primary cortical neurons (10). 
 VEGF and BDNF are both present during early 
neuronal development.(11) Among other mechanisms, it has 
been reported that VEGF stimulates brain endothelial cells 
(BEC) to secrets BDNF (12), which promotes proliferation 
and differentiation of progenitor cells (13) and in higher 
level, it can improves functional recovery (14). Since BDNF 
can be produced by endothelial cells, the BDNF can later 
increase neuronal migration to ischemic area.(1) BDNF also 
have neuroprotective effects.(15) In the other hand, BDNF 
also regulates VEGF secretion and angiogenesis through 
tryptomyosin receptor kinase B (TrkB), phospholipase C 
(PLC)-ɣ, protein kinase C (PKC)-α and Hypoxia-inducible 
factor (HIF)-1α signaling pathways.(16)
 In Framingham study, lower BDNF and higher VEGF 
were  associated  with  the  increase  of  incident  stroke 
risk.(10) In ischemic stroke condition, increasing VEGF 
and BDNF will promote neurogenesis and neuroplasticity 
in the ischemic boundary zone (17), and also create vascular 
niche for neurogenesis (18) and  neuroblast migration to 
penumbra (1). 
 Many studies for stroke therapy are directed to improve 
the process of endogenous repair with marker VEGF or 
BDNF, such as through the provision of phosphodiesterase-5 
inhibitors (19), erythropoietin (20), statins (13). In this 
study, we observed the VEGF and BDNF levels of subjects 
with ischemic stroke in different onset time, which has not 
been conducted in Indonesian patients. This study can add 
information regarding VEGF and BDNF levels in different 
time stage of ischemic stroke patients. 
Methods
conduct MRI were excluded. Most subjects got medication 
of amlodipine, simvastatin, ACE inhibitor and aspirin.
Specimen Collection
Blood were collected intravenously, serum were separated 
by centrifugation and aliquots were stored frozen at -21oC 
for subsequent batched analysis for all parameter. VEGF 
and BDNF levels were measured using multiplex method 
(catalog number: LXSAHM-03, R&D System, Minneapolis, 
USA), with luminex Magpix instrument. Multiplex method 
provided multiple parameters by immunoassay principle at 
the same time with a high speed. We used BDNF reagents 
exclude pro-BDNF and the test was conducted at Prodia 
research laboratory, Jakarta.  
Statistical Analysis
The normal distribution was analyzed by Shapiro-Wilk, and 
the difference significances between groups were analyzed 
by t-test analysis or Mann-Whitney, depends on distribution 
results. Meanwhile correlation significances between log 
VEGF and BDNF were analyzed by Pearson analysis.
We conducted a study to identify the difference between 
VEGF and BDNF levels in each group. Total ischemic 
stroke subjects were 51, which were divided into: 8 subjects 
for group A, 18 subjects for group B and 25 subjects for 
group C.  
 General characteristic of 51 subjects for age, body 
mass index (BMI), systole blood pressure (SBP), diastole 
blood pressure (DBP) and the results of normality test with 
Shapiro-Wilk analysis data was reported in Table 1. Age, 
BMI and BDNF was distributed normally, whereas VEGF 
was not distributed normally.
 As described in Table 2, there was no significant 
difference between the group onset for age, DBP, SBP and 
Results
Variable Min Max Mean±SD Median p*
Age (Year) 38 76 57.18±9.87 55 0.343*
BMI (Kg/m2) 18.25 34.05 24.04±11.63 23.88 0.086*
SBP (mmHg) 57 159 87.9412±17.2446 89 0
DBP (mmHg) 100 220 146.176±695.548 140 0.004
VEGF (pg/mL) 13.99 459.02 83.8761±72.2411 67.78 0
BDNF (pg/mL) 6105 4,000.00 18860±6844.67 18,343.00 0.536*
*Distribution assessment with Shapiro-Wilk test, SD: standard deviation.
Table 1. General characteristics of subjects and normality test 
(n=51).
A cross sectional study was designed. Study subjects were 
51 ischemic stroke subjects, aged 30-80 years old, recruited 
from Gatot Subroto Army Central Hospital, Jakarta, 
Indonesia.  Ischemic stroke was diagnosed by neurologist, 
based on clinical examination and magnetic resonance 
imaging (MRI) result. Study protocol was approved 
by the Ethical Commission of Faculty of Medicine, 
Hassanudin University (No. 0024/H04.8.4.5.31/PP36-
KOMETIK/2015). Subjects were divided into 3 groups 
based on onset time of stroke: <7 days (group A), 7-30 days 
(group B) and >30 days (Group C). Subjects with medical 
history of carcinoma, hematoma subdural, global ischemia, 
blood clotting disorders, seizures, or those who could not 
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Discussion
VEGF levels were significantly different between group 
B and C, whereas group B had the highest VEGF level, 
while group C had the lowest VEGF level. These results 
are in line with the process of angiogenesis that occurs due 
to ischemic stroke with peak between day 7th to 14th after 
onset and then decreased.(21) The profile is also similar to 
the research results of Hayashi, et al., where VEGF levels 
increased immediately after the stroke and decreased until 
day 21st  of observation. It is known that angiogenic genes 
increase 1 hour after onset and some genes remain elevated 
until day 21st, as well as the total number of vessel in the 
cortex. This suggests that angiogenesis is still running.(22) 
The peak of endogenous neurorepair processes including 
angiogenesis occurs at day 6th after onset and decrease by 1 
month. It opens up opportunities for restoration therapy post 
stroke with a longer time.(23)
 BDNF levels were significantly different between 
group B and C. BDNF level of group B was lower than 
group A, and group C had the highest BDNF level. This 
suggests that BDNF level was increased 2 weeks after 
VEGF level increased. This phenomenon was also observed 
in study of Louissaint, et al., although triggered by different 
factors. It shows that BDNF level is changes slightly in the 
first week, but then increased steadily. The delayed rise of 
BDNF level was contrasted with VEGF level, which was 
increased rapidly until 1-2 weeks but then decreased.(12) 
Others study showed that VEGF could stimulate BECs 
in order to secrete BDNF.(18) The resulted BDNF could 
support neuron differentiation and migration.(12) In current 
study, the highest level of BDNF was observed after 30 days 
onset, suggesting that an important role of BDNF in a long 
period of time after the onset for regeneration and repair, 
such as maintaining neuronal survival and plasticity. 
 VEGF and BDNF are involved in process of 
neurogenesis and plasticity of synaptic.(24) Lin, et al., 
(A) (B) (C) A vs. B A vs. C B vs. C
BMI 27.43±4.18 24.86±2.85 24.48±3.36 0.121 0.08 0.685
Age 61.75±11.68 57.72±10.70 55.32±8.45 0.442 0.207 0.518
SBP 74.83±29.95 88.17±16.57 83.96±9.97 0.592* 0.234* 0.261*
DBP 142.38±34.43 145.17±30.50 148.12±20.86 0.538* 0.355* 0.394*
VEGF 69.23±41.58 110.45±98.30 69.43±52.01 0.273 0.584 0.034**
BDNF 18291±6437.62 15919±5599.68 21160±7155.45 0.455 0.174 0.007**
*Mann Whitney, ** Independent t-test 
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Table 2. Comparison of biomarkers among groups. Results were shown as mean±SD.
V
EG
F 
M
ea
n
BD
N
F 
M
ea
n
Group
Group
Figure 1. Comparison between VEGF and BDNF mean 
among groups.
BMI. The levels of VEGF and BDNF were significantly 
different between group B and C, while the other group did 
not significantly different. VEGF level of group B was the 
highest and the one of group C was the lowest. Meanwhile, 
BDNF levels of group B was the lowest and the one of group 
C was the highest (Figure 1). Using Pearson correlation 
test, it was found that there was no significant correlation 
between VEGF and BDNF in each group (Table 3). 
Group P R
A (n=8) 0.399 0.321
B (n=18) 0.083 0.42
C (n=25) 0.564 -0.116
Table 3. Correlation analysis between VEGF and BDNF.
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Conclusion
VEGF and BDNF in ischemic stroke have positive effect on 
long-term potentiation, neural remodeling, and functional 
motor recovery.(11) Each stage of time after ischemic 
stroke has different levels of VEGF and BDNF, this is 
related to the different recovery activities like angiogenesis, 
neurogenesis and plasticity and angiogenesis process was 
optimum in 7-30 days after onset. In onset more than 30 
days, low VEGF with high BDNF probably needed for next 
regeneration process such as maintaining neuronal survival 
and plasticity. Assessing the levels of VEGF and BDNF in 
ischemic stroke could possibly be used to determine the 
recovery process. Yet, it needs more study to determine the 
recovery process.
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showed that BDNF also increased VEGF through TrkB 
and HIF-1 signal pathway.(16,25) Low BDNF and high 
VEGF levels were reported in patients with vascular risk, 
like atherosclerosis and cerebrovascular disease.(11) This 
profile similar to our result in group B but not in group C. 
This suggests that correlation between VEGF and BDNF 
can not be calculated, but the profile of the results can be 
assessed.
